UnitedHealth Group Validates a Self-Administered COVID-19 Test
UnitedHealth Group (NYSE: UNH) on Wednesday announced results of a 500-patient study that it hopes will lead the Food and Drug Administration to soften its generally negative stance on self-administered testing. The study found tests conducted using patient-collected samples accurately detected COVID-19 in more than 90% of positive patients, which is just as good as swabs taken by healthcare professionals.
Currently, testing for COVID-19 requires a trained clinician to collect a sample from deep in the nasal cavity, which means they need to dip into a dwindling supply of personal protective equipment with each patient.
Image source: Getty Images.
Source Fool.com
